
Promoting food production, with creativity, science, and fundamentally our own resources, is today one of Cuba's priorities included in the State Budget for 2022.
Industrial production has begun of Cuba’s candidate vaccines Soberana 02 and Abdala (CIGB-66), two of the four developed on the island to combat COVID-19, with progress advancing at BioCubaFarma facilities.
Experiences on the control and management of Covid-19, cancer immunotherapy and agricultural biotechnology on Wednesday focus the debates of the BioHabana 2022 International Congress, scheduled until Friday.
Read more Covid-19, cancer and agricultural biotechnology focus BioHabana 2022Page 331 of 499